Skip to content

Jade Biosciences, Inc.

JBIO

CIK 0001798749

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$135.85M
−171.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$14.01
+78.6% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$78.13M
Q1 May 2026
Cash
$55.09M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
49.36M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings